Randomized, Single Blind, Placebo Controlled, to Evaluate Efficacy and Safety of Polidocanol Injectable Foam for Treatment of Symptomatic, Visible Varicose Veins With SFJ Incompetence

Last updated: April 19, 2021
Sponsor: Boston Scientific Corporation
Overall Status: Completed

Phase

2/3

Condition

Occlusions

Varicose Veins

Vascular Diseases

Treatment

N/A

Clinical Study ID

NCT00758420
VAP.VV013
  • Ages 18-65
  • All Genders

Study Summary

The purpose of this study is to evaluate the effectiveness of polidocanol injectable foam in the relief of symptoms, improvement of appearance, and overall effectiveness and safety in the treatment of varicose veins compared to placebo.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Males and Females 18-65 years old
  • VEINES Sym Score less than 75 points
  • Varicose Vein clinical classification CEAP 2, 3, 4, or 5
  • Incompetence of SFJ associated with incompetence of the GSV or other major accessoryvein
  • Superficial venous disease manifested by both symptoms and visible varicosities
  • Ability to comprehend and sign an informed consent document and completed studyquestionnaires in English

Exclusion

Exclusion Criteria:

  • Incompetence of the SSV which substantially contributes to the filling of visiblevaricose veins
  • Current or previous Deep Vein Thrombosis
  • Leg obesity
  • Peripheral arterial disease in the leg to be treated
  • Reduced mobility
  • Planned prolonged travel with limited mobility with in 4 weeks of treatment
  • History of pulmonary embolism or stroke
  • Major surgery, prolonged hospitalization or pregnancy within 3 months
  • Current anticoagulation therapy (within 7 days of enrollment)
  • Participation in a clinical study involving a investigational product within 3 months
  • Major co-existing disease or clinically significant laboratory abnormalities
  • Known allergic response to polidocanol or heparin or severe and/or multiple allergicreactions
  • Women of childbearing potential not using effective contraception one month prior toenrollment and/or unwilling to continue while on study
  • Pregnant or lactating women
  • Current alcohol or drug abuse

Study Design

Total Participants: 77
Study Start date:
October 01, 2008
Estimated Completion Date:
August 31, 2009

Study Description

The purpose of this study is to evaluate the efficacy of polidocanol injectable foam vs placebo treatments in relief of symptoms using two disease specific questionnaires, establishment of a minimally important difference (MID) for the questionnaires, improvement in the appearance of visible varicosities by a patient and medical assessments aided by pre and post treatment photographs, and a central independent assessor evaluating pre and post treatment photographs. In addition, the study will evaluate the efficacy of polidocanol injectable foam vs the placebo treatment in the elimination of SFJ reflux or occlusion of the treated vein, and to determine whether the placebo procedure blinds the patient to treatment assignment.

Connect with a study center

  • Scottsdale, Arizona 85255
    United States

    Site Not Available

  • New York, New York 10016
    United States

    Site Not Available

  • Charlotte, North Carolina 28207
    United States

    Site Not Available

  • empty

    Winston Salem, North Carolina 27157
    United States

    Site Not Available

  • Winston-Salem, North Carolina 27157
    United States

    Site Not Available

  • Bellevue, Washington 98004
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.